Domain | Topic | Number of questions |
---|---|---|
Study design | Target population | 4 |
Trial design | 6 | |
Study endpoint | 3 | |
Timing of study after stroke | 4 | |
Intervention | 4 | |
Medication | 1 | |
Comparator | 3 | |
Statistical analysis | 2 | |
Safety reporting | 1 | |
Regulatory | Intended cell therapy use | 4 |
Cell therapy processing | 9 | |
Expertise in submission of clinical trial applications to regulators | 1 | |
Ethical | Patient and Public Involvement in Research (PPIR) | 10 |
Study safety committee | 1 | |
Health economic | Cost outcomes | 5 |